nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Optic atrophy—Esomeprazole—Barrett's esophagus	0.0352	0.0383	CcSEcCtD
Cyproterone acetate—Optic atrophy—Omeprazole—Barrett's esophagus	0.0352	0.0383	CcSEcCtD
Cyproterone acetate—Nodule—Esomeprazole—Barrett's esophagus	0.0229	0.025	CcSEcCtD
Cyproterone acetate—Nodule—Omeprazole—Barrett's esophagus	0.0229	0.025	CcSEcCtD
Cyproterone acetate—Hypochromic anaemia—Esomeprazole—Barrett's esophagus	0.0174	0.0189	CcSEcCtD
Cyproterone acetate—Hypochromic anaemia—Omeprazole—Barrett's esophagus	0.0174	0.0189	CcSEcCtD
Cyproterone acetate—Hernia—Omeprazole—Barrett's esophagus	0.0144	0.0157	CcSEcCtD
Cyproterone acetate—Hernia—Esomeprazole—Barrett's esophagus	0.0144	0.0157	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.0124	0.151	CbGpPWpGaD
Cyproterone acetate—Urine abnormality—Esomeprazole—Barrett's esophagus	0.0122	0.0133	CcSEcCtD
Cyproterone acetate—Urine abnormality—Omeprazole—Barrett's esophagus	0.0122	0.0133	CcSEcCtD
Cyproterone acetate—Sleep disturbance—Esomeprazole—Barrett's esophagus	0.012	0.0131	CcSEcCtD
Cyproterone acetate—Sleep disturbance—Omeprazole—Barrett's esophagus	0.012	0.0131	CcSEcCtD
Cyproterone acetate—Hepatic necrosis—Esomeprazole—Barrett's esophagus	0.0116	0.0126	CcSEcCtD
Cyproterone acetate—Hepatic necrosis—Omeprazole—Barrett's esophagus	0.0116	0.0126	CcSEcCtD
Cyproterone acetate—Urine analysis abnormal—Esomeprazole—Barrett's esophagus	0.0115	0.0125	CcSEcCtD
Cyproterone acetate—Urine analysis abnormal—Omeprazole—Barrett's esophagus	0.0115	0.0125	CcSEcCtD
Cyproterone acetate—Polyp—Esomeprazole—Barrett's esophagus	0.0111	0.0121	CcSEcCtD
Cyproterone acetate—Polyp—Omeprazole—Barrett's esophagus	0.0111	0.0121	CcSEcCtD
Cyproterone acetate—Optic neuritis—Omeprazole—Barrett's esophagus	0.011	0.0119	CcSEcCtD
Cyproterone acetate—Optic neuritis—Esomeprazole—Barrett's esophagus	0.011	0.0119	CcSEcCtD
Cyproterone acetate—Encephalopathy—Esomeprazole—Barrett's esophagus	0.0105	0.0114	CcSEcCtD
Cyproterone acetate—Encephalopathy—Omeprazole—Barrett's esophagus	0.0105	0.0114	CcSEcCtD
Cyproterone acetate—Cyst—Esomeprazole—Barrett's esophagus	0.0101	0.011	CcSEcCtD
Cyproterone acetate—Cyst—Omeprazole—Barrett's esophagus	0.0101	0.011	CcSEcCtD
Cyproterone acetate—Dysmenorrhoea—Esomeprazole—Barrett's esophagus	0.00741	0.00808	CcSEcCtD
Cyproterone acetate—Dysmenorrhoea—Omeprazole—Barrett's esophagus	0.00741	0.00808	CcSEcCtD
Cyproterone acetate—Glossitis—Esomeprazole—Barrett's esophagus	0.00732	0.00797	CcSEcCtD
Cyproterone acetate—Glossitis—Omeprazole—Barrett's esophagus	0.00732	0.00797	CcSEcCtD
Cyproterone acetate—Leukocytosis—Omeprazole—Barrett's esophagus	0.00717	0.00782	CcSEcCtD
Cyproterone acetate—Leukocytosis—Esomeprazole—Barrett's esophagus	0.00717	0.00782	CcSEcCtD
Cyproterone acetate—Creatinine increased—Omeprazole—Barrett's esophagus	0.00708	0.00772	CcSEcCtD
Cyproterone acetate—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00708	0.00772	CcSEcCtD
Cyproterone acetate—Injection site reaction—Esomeprazole—Barrett's esophagus	0.0067	0.0073	CcSEcCtD
Cyproterone acetate—Injection site reaction—Omeprazole—Barrett's esophagus	0.0067	0.0073	CcSEcCtD
Cyproterone acetate—Fluid retention—Omeprazole—Barrett's esophagus	0.0064	0.00697	CcSEcCtD
Cyproterone acetate—Fluid retention—Esomeprazole—Barrett's esophagus	0.0064	0.00697	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00622	0.0758	CbGpPWpGaD
Cyproterone acetate—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00613	0.00668	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00613	0.00668	CcSEcCtD
Cyproterone acetate—Neoplasm—Omeprazole—Barrett's esophagus	0.0061	0.00664	CcSEcCtD
Cyproterone acetate—Neoplasm—Esomeprazole—Barrett's esophagus	0.0061	0.00664	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00603	0.00657	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00603	0.00657	CcSEcCtD
Cyproterone acetate—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00588	0.00641	CcSEcCtD
Cyproterone acetate—Abnormal vision—Omeprazole—Barrett's esophagus	0.00588	0.00641	CcSEcCtD
Cyproterone acetate—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00565	0.00616	CcSEcCtD
Cyproterone acetate—Sleep disorder—Omeprazole—Barrett's esophagus	0.00565	0.00616	CcSEcCtD
Cyproterone acetate—Hepatic failure—Omeprazole—Barrett's esophagus	0.00545	0.00593	CcSEcCtD
Cyproterone acetate—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00545	0.00593	CcSEcCtD
Cyproterone acetate—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00542	0.00591	CcSEcCtD
Cyproterone acetate—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00542	0.00591	CcSEcCtD
Cyproterone acetate—Hot flush—Omeprazole—Barrett's esophagus	0.00523	0.0057	CcSEcCtD
Cyproterone acetate—Hot flush—Esomeprazole—Barrett's esophagus	0.00523	0.0057	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00519	0.00565	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00519	0.00565	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00491	0.0599	CbGpPWpGaD
Cyproterone acetate—Migraine—Omeprazole—Barrett's esophagus	0.00482	0.00525	CcSEcCtD
Cyproterone acetate—Migraine—Esomeprazole—Barrett's esophagus	0.00482	0.00525	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00472	0.0575	CbGpPWpGaD
Cyproterone acetate—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00458	0.00499	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00458	0.00499	CcSEcCtD
Cyproterone acetate—Breast disorder—Esomeprazole—Barrett's esophagus	0.00442	0.00482	CcSEcCtD
Cyproterone acetate—Breast disorder—Omeprazole—Barrett's esophagus	0.00442	0.00482	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00441	0.0048	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00441	0.0048	CcSEcCtD
Cyproterone acetate—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00432	0.0047	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00432	0.0047	CcSEcCtD
Cyproterone acetate—Muscular weakness—Omeprazole—Barrett's esophagus	0.00432	0.0047	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00432	0.0047	CcSEcCtD
Cyproterone acetate—Asthma—Esomeprazole—Barrett's esophagus	0.00423	0.00461	CcSEcCtD
Cyproterone acetate—Asthma—Omeprazole—Barrett's esophagus	0.00423	0.00461	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00417	0.0509	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Omeprazole—Barrett's esophagus	0.00415	0.00452	CcSEcCtD
Cyproterone acetate—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00415	0.00452	CcSEcCtD
Cyproterone acetate—Sweating increased—Omeprazole—Barrett's esophagus	0.00412	0.00449	CcSEcCtD
Cyproterone acetate—Sweating increased—Esomeprazole—Barrett's esophagus	0.00412	0.00449	CcSEcCtD
Cyproterone acetate—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00391	0.00426	CcSEcCtD
Cyproterone acetate—Pollakiuria—Omeprazole—Barrett's esophagus	0.00391	0.00426	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.0039	0.00424	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.0039	0.00424	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00386	0.00421	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00386	0.00421	CcSEcCtD
Cyproterone acetate—Weight increased—Esomeprazole—Barrett's esophagus	0.00385	0.00419	CcSEcCtD
Cyproterone acetate—Weight increased—Omeprazole—Barrett's esophagus	0.00385	0.00419	CcSEcCtD
Cyproterone acetate—Weight decreased—Omeprazole—Barrett's esophagus	0.00383	0.00417	CcSEcCtD
Cyproterone acetate—Weight decreased—Esomeprazole—Barrett's esophagus	0.00383	0.00417	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00373	0.0454	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00371	0.0452	CbGpPWpGaD
Cyproterone acetate—Renal failure—Omeprazole—Barrett's esophagus	0.00371	0.00404	CcSEcCtD
Cyproterone acetate—Renal failure—Esomeprazole—Barrett's esophagus	0.00371	0.00404	CcSEcCtD
Cyproterone acetate—Jaundice—Esomeprazole—Barrett's esophagus	0.00368	0.004	CcSEcCtD
Cyproterone acetate—Jaundice—Omeprazole—Barrett's esophagus	0.00368	0.004	CcSEcCtD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00366	0.0446	CbGpPWpGaD
Cyproterone acetate—Haematuria—Omeprazole—Barrett's esophagus	0.0036	0.00392	CcSEcCtD
Cyproterone acetate—Haematuria—Esomeprazole—Barrett's esophagus	0.0036	0.00392	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00357	0.00389	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00357	0.00389	CcSEcCtD
Cyproterone acetate—Hepatitis—Omeprazole—Barrett's esophagus	0.00339	0.00369	CcSEcCtD
Cyproterone acetate—Hepatitis—Esomeprazole—Barrett's esophagus	0.00339	0.00369	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00333	0.00362	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00333	0.00362	CcSEcCtD
Cyproterone acetate—Visual impairment—Esomeprazole—Barrett's esophagus	0.00326	0.00355	CcSEcCtD
Cyproterone acetate—Visual impairment—Omeprazole—Barrett's esophagus	0.00326	0.00355	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Omeprazole—Barrett's esophagus	0.0032	0.00349	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.0032	0.00349	CcSEcCtD
Cyproterone acetate—Eye disorder—Esomeprazole—Barrett's esophagus	0.00316	0.00345	CcSEcCtD
Cyproterone acetate—Eye disorder—Omeprazole—Barrett's esophagus	0.00316	0.00345	CcSEcCtD
Cyproterone acetate—Immune system disorder—Omeprazole—Barrett's esophagus	0.00306	0.00333	CcSEcCtD
Cyproterone acetate—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00306	0.00333	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00305	0.00332	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00305	0.00332	CcSEcCtD
Cyproterone acetate—Chills—Esomeprazole—Barrett's esophagus	0.00304	0.00331	CcSEcCtD
Cyproterone acetate—Chills—Omeprazole—Barrett's esophagus	0.00304	0.00331	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00301	0.0367	CbGpPWpGaD
Cyproterone acetate—Alopecia—Esomeprazole—Barrett's esophagus	0.00299	0.00326	CcSEcCtD
Cyproterone acetate—Alopecia—Omeprazole—Barrett's esophagus	0.00299	0.00326	CcSEcCtD
Cyproterone acetate—Mental disorder—Omeprazole—Barrett's esophagus	0.00297	0.00323	CcSEcCtD
Cyproterone acetate—Mental disorder—Esomeprazole—Barrett's esophagus	0.00297	0.00323	CcSEcCtD
Cyproterone acetate—Malnutrition—Omeprazole—Barrett's esophagus	0.00295	0.00321	CcSEcCtD
Cyproterone acetate—Malnutrition—Esomeprazole—Barrett's esophagus	0.00295	0.00321	CcSEcCtD
Cyproterone acetate—Tension—Esomeprazole—Barrett's esophagus	0.00289	0.00315	CcSEcCtD
Cyproterone acetate—Tension—Omeprazole—Barrett's esophagus	0.00289	0.00315	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00273	0.00298	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00273	0.00298	CcSEcCtD
Cyproterone acetate—Anaemia—Omeprazole—Barrett's esophagus	0.00272	0.00297	CcSEcCtD
Cyproterone acetate—Anaemia—Esomeprazole—Barrett's esophagus	0.00272	0.00297	CcSEcCtD
Cyproterone acetate—Agitation—Esomeprazole—Barrett's esophagus	0.00271	0.00295	CcSEcCtD
Cyproterone acetate—Agitation—Omeprazole—Barrett's esophagus	0.00271	0.00295	CcSEcCtD
Cyproterone acetate—Malaise—Omeprazole—Barrett's esophagus	0.00266	0.0029	CcSEcCtD
Cyproterone acetate—Malaise—Esomeprazole—Barrett's esophagus	0.00266	0.0029	CcSEcCtD
Cyproterone acetate—Leukopenia—Esomeprazole—Barrett's esophagus	0.00264	0.00287	CcSEcCtD
Cyproterone acetate—Leukopenia—Omeprazole—Barrett's esophagus	0.00264	0.00287	CcSEcCtD
Cyproterone acetate—Cough—Esomeprazole—Barrett's esophagus	0.00257	0.0028	CcSEcCtD
Cyproterone acetate—Cough—Omeprazole—Barrett's esophagus	0.00257	0.0028	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00249	0.00271	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00249	0.00271	CcSEcCtD
Cyproterone acetate—Discomfort—Esomeprazole—Barrett's esophagus	0.00248	0.0027	CcSEcCtD
Cyproterone acetate—Discomfort—Omeprazole—Barrett's esophagus	0.00248	0.0027	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.0024	0.0293	CbGpPWpGaD
Cyproterone acetate—Shock—Esomeprazole—Barrett's esophagus	0.00237	0.00258	CcSEcCtD
Cyproterone acetate—Shock—Omeprazole—Barrett's esophagus	0.00237	0.00258	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00236	0.00257	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00236	0.00257	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00236	0.00257	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00236	0.00257	CcSEcCtD
Cyproterone acetate—Tachycardia—Esomeprazole—Barrett's esophagus	0.00235	0.00256	CcSEcCtD
Cyproterone acetate—Tachycardia—Omeprazole—Barrett's esophagus	0.00235	0.00256	CcSEcCtD
Cyproterone acetate—Skin disorder—Esomeprazole—Barrett's esophagus	0.00234	0.00255	CcSEcCtD
Cyproterone acetate—Skin disorder—Omeprazole—Barrett's esophagus	0.00234	0.00255	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00233	0.00253	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00233	0.00253	CcSEcCtD
Cyproterone acetate—Anorexia—Omeprazole—Barrett's esophagus	0.00229	0.0025	CcSEcCtD
Cyproterone acetate—Anorexia—Esomeprazole—Barrett's esophagus	0.00229	0.0025	CcSEcCtD
Cyproterone acetate—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00214	0.00234	CcSEcCtD
Cyproterone acetate—Dyspnoea—Omeprazole—Barrett's esophagus	0.00214	0.00234	CcSEcCtD
Cyproterone acetate—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00212	0.00231	CcSEcCtD
Cyproterone acetate—Dyspepsia—Omeprazole—Barrett's esophagus	0.00212	0.00231	CcSEcCtD
Cyproterone acetate—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00209	0.00228	CcSEcCtD
Cyproterone acetate—Decreased appetite—Omeprazole—Barrett's esophagus	0.00209	0.00228	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00208	0.00226	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00208	0.00226	CcSEcCtD
Cyproterone acetate—Fatigue—Omeprazole—Barrett's esophagus	0.00207	0.00226	CcSEcCtD
Cyproterone acetate—Fatigue—Esomeprazole—Barrett's esophagus	0.00207	0.00226	CcSEcCtD
Cyproterone acetate—Constipation—Esomeprazole—Barrett's esophagus	0.00206	0.00224	CcSEcCtD
Cyproterone acetate—Constipation—Omeprazole—Barrett's esophagus	0.00206	0.00224	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—Barrett's esophagus	0.00205	0.0249	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00198	0.00216	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00198	0.00216	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00197	0.00214	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00197	0.00214	CcSEcCtD
Cyproterone acetate—Urticaria—Omeprazole—Barrett's esophagus	0.00191	0.00208	CcSEcCtD
Cyproterone acetate—Urticaria—Esomeprazole—Barrett's esophagus	0.00191	0.00208	CcSEcCtD
Cyproterone acetate—Abdominal pain—Omeprazole—Barrett's esophagus	0.0019	0.00207	CcSEcCtD
Cyproterone acetate—Body temperature increased—Omeprazole—Barrett's esophagus	0.0019	0.00207	CcSEcCtD
Cyproterone acetate—Abdominal pain—Esomeprazole—Barrett's esophagus	0.0019	0.00207	CcSEcCtD
Cyproterone acetate—Body temperature increased—Esomeprazole—Barrett's esophagus	0.0019	0.00207	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00177	0.00193	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00177	0.00193	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—CYP26A1—Barrett's esophagus	0.00176	0.0215	CbGpPWpGaD
Cyproterone acetate—Asthenia—Omeprazole—Barrett's esophagus	0.00173	0.00188	CcSEcCtD
Cyproterone acetate—Asthenia—Esomeprazole—Barrett's esophagus	0.00173	0.00188	CcSEcCtD
Cyproterone acetate—Pruritus—Esomeprazole—Barrett's esophagus	0.0017	0.00185	CcSEcCtD
Cyproterone acetate—Pruritus—Omeprazole—Barrett's esophagus	0.0017	0.00185	CcSEcCtD
Cyproterone acetate—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00165	0.00179	CcSEcCtD
Cyproterone acetate—Diarrhoea—Omeprazole—Barrett's esophagus	0.00165	0.00179	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00162	0.0197	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.0016	0.0195	CbGpPWpGaD
Cyproterone acetate—Dizziness—Omeprazole—Barrett's esophagus	0.00159	0.00173	CcSEcCtD
Cyproterone acetate—Dizziness—Esomeprazole—Barrett's esophagus	0.00159	0.00173	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00158	0.0192	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—Barrett's esophagus	0.00155	0.0189	CbGpPWpGaD
Cyproterone acetate—Vomiting—Omeprazole—Barrett's esophagus	0.00153	0.00167	CcSEcCtD
Cyproterone acetate—Vomiting—Esomeprazole—Barrett's esophagus	0.00153	0.00167	CcSEcCtD
Cyproterone acetate—Rash—Esomeprazole—Barrett's esophagus	0.00152	0.00165	CcSEcCtD
Cyproterone acetate—Rash—Omeprazole—Barrett's esophagus	0.00152	0.00165	CcSEcCtD
Cyproterone acetate—Dermatitis—Omeprazole—Barrett's esophagus	0.00152	0.00165	CcSEcCtD
Cyproterone acetate—Dermatitis—Esomeprazole—Barrett's esophagus	0.00152	0.00165	CcSEcCtD
Cyproterone acetate—Headache—Omeprazole—Barrett's esophagus	0.00151	0.00164	CcSEcCtD
Cyproterone acetate—Headache—Esomeprazole—Barrett's esophagus	0.00151	0.00164	CcSEcCtD
Cyproterone acetate—Nausea—Omeprazole—Barrett's esophagus	0.00143	0.00156	CcSEcCtD
Cyproterone acetate—Nausea—Esomeprazole—Barrett's esophagus	0.00143	0.00156	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—BMP4—Barrett's esophagus	0.00134	0.0163	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00129	0.0158	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00123	0.0149	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—Barrett's esophagus	0.00118	0.0144	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.00117	0.0142	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APC—Barrett's esophagus	0.00101	0.0123	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000982	0.012	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000949	0.0116	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000861	0.0105	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000849	0.0103	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000838	0.0102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00081	0.00987	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000801	0.00976	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000726	0.00885	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000679	0.00828	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000644	0.00785	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.00064	0.0078	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000583	0.0071	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—Barrett's esophagus	0.00058	0.00707	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000504	0.00615	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000446	0.00543	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000442	0.00539	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR1I2—Barrett's esophagus	0.000409	0.00498	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000393	0.00479	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000383	0.00466	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGES—Barrett's esophagus	0.000361	0.0044	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000318	0.00387	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NR1I2—Barrett's esophagus	0.00031	0.00378	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000279	0.0034	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP26A1—Barrett's esophagus	0.000273	0.00333	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000273	0.00333	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000263	0.00321	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000212	0.00258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000202	0.00246	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC9A1—Barrett's esophagus	0.000197	0.0024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000159	0.00194	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—Barrett's esophagus	0.000134	0.00164	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—Barrett's esophagus	0.000102	0.00124	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—Barrett's esophagus	9e-05	0.0011	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—Barrett's esophagus	7.08e-05	0.000862	CbGpPWpGaD
